Sentinel node and breast cancer: A state-of-the-art in 2019

Titre traduit de la contribution: Ganglion sentinelle et cancer du sein: où en est-on en 2019 ?

J. Zeitoun, G. Babin, J. F. Lebrun

Résultats de recherche: Contribution à un journalBrève enquêteRevue par des pairs

6 Citations (Scopus)

Résumé

Since 1994 and Giuliano's description of sentinel lymph node technique, this procedure has considerably improved and is nowadays, one of the essential pillars in the management of breast cancer. Neoadjuvant chemotherapy (NAC) is effective on regional control, especially on axillary lymph node. Various learned societies recommend that the initial proved GS can be realized before (CNGOF 2010, Saint-Paul de Vence 2013, ESMO 2015, St-Gallen 2015, NCCN 2016) or after (ASCO 2014, ESMO 2015, Saint-Gallen 2015) CNA when the patient is considered like N0. In patients with initial lymph node involvement, GS searching it is not yet recommended. SLN detection before NAC remains an important prognostic factor especially in N+ patients before surgery. The purpose of this article was a reviewing of medical literature regarding possible indications for SLN detection and axillary dissection in patients with NAC according to sentinel lymph node status. The secondary objective was to put forward different perspectives and studies dealing with this subject. The complete pathological response appears to be an important selection criterion for proposing SLN to these patients and avoiding a “useless” AD. It is important to include patients in the trials to make recommendations progress on SLN after NAC and avoid a rate of uninjured AD.

Titre traduit de la contributionGanglion sentinelle et cancer du sein: où en est-on en 2019 ?
langue originaleAnglais
Pages (de - à)522-526
Nombre de pages5
journalGynecologie Obstetrique Fertilite et Senologie
Volume47
Numéro de publication6
Les DOIs
étatPublié - 1 juin 2019
Modification externeOui

Contient cette citation